Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Elkrief, LaureHernandez-Gea, Virginia
Senzolo, Marco
Albillos, Agustin
Baiges, Anna
Berzigotti, Annalisa
Bureau, Christophe
Murad, Sarwa Darwish
De Gottardi, Andrea
Durand, François
Garcia-Pagan, Juan-Carlos
Lisman, Ton
Mandorfer, Mattias
McLin, Valérie
Moga, Lucile
Nery, Filipe
Northup, Patrick
Nuzzo, Alexandre
Paradis, Valérie
Patch, David
Payancé, Audrey
Plaforet, Vincent
Plessier, Aurélie
Poisson, Johanne
Roberts, Lara
Salem, Riad
Sarin, Shiv
Shukla, Akash
Toso, Christian
Tripathi, Dhiraj
Valla, Dominique
Ronot, Maxime
Rautou, Pierre-Emmanuel
Publication date
2024-07-09Subject
Gastroenterology
Metadata
Show full item recordAbstract
Portal vein thrombosis (PVT) refers to the development of a non-malignant obstruction of the portal vein, its branches, its radicles, or a combination. This Review first provides a comprehensive overview of all aspects of PVT, namely the specifics of the portal venous system, the risk factors for PVT, the pathophysiology of portal hypertension in PVT, the interest in non-invasive tests, as well as therapeutic approaches including the effect of treating risk factors for PVT or cause of cirrhosis, anticoagulation, portal vein recanalisation by interventional radiology, and prevention and management of variceal bleeding in patients with PVT. Specific issues are also addressed including portal cholangiopathy, mesenteric ischaemia and intestinal necrosis, quality of life, fertility, contraception and pregnancy, and PVT in children. This Review will then present endpoints for future clinical studies in PVT, both in patients with and without cirrhosis, agreed by a large panel of experts through a Delphi consensus process. These endpoints include classification of portal vein thrombus extension, classification of PVT evolution, timing of assessment of PVT, and global endpoints for studies on PVT including clinical outcomes. These endpoints will help homogenise studies on PVT and thus facilitate reporting, comparison between studies, and validation of future studies and trials on PVT.Citation
Elkrief L, Hernandez-Gea V, Senzolo M, Albillos A, Baiges A, Berzigotti A, Bureau C, Murad SD, De Gottardi A, Durand F, Garcia-Pagan JC, Lisman T, Mandorfer M, McLin V, Moga L, Nery F, Northup P, Nuzzo A, Paradis V, Patch D, Payancé A, Plaforet V, Plessier A, Poisson J, Roberts L, Salem R, Sarin S, Shukla A, Toso C, Tripathi D, Valla D, Ronot M, Rautou PE; ERN RARE-LIVER and VALDIG, an EASL consortium. Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies. Lancet Gastroenterol Hepatol. 2024 Sep;9(9):859-883. doi: 10.1016/S2468-1253(24)00155-9. Epub 2024 Jul 9. PMID: 38996577.Type
ArticleOther
Additional Links
http://www.sciencedirect.com/science/journal/24681253PMID
38996577Publisher
Elsevierae974a485f413a2113503eed53cd6c53
10.1016/S2468-1253(24)00155-9